How to Get Reliable FTIR Identification Every Time with the Agilent Cary 630

Your raw material just failed its FTIR identity check. The match score came back at 87%, the batch is on hold and three people are standing around a spectrometer debating whether to reject a container of perfectly good excipient.

Here is the hard truth: in most cases, the material is fine. The instrument is fine. The problem is a misunderstanding of what FTIR matching actually measures, and it is costing pharmaceutical QC labs hours of unnecessary retesting, false rejections and eroded confidence in a technology that is genuinely excellent at its job.

This article unpacks the three real causes of low match scores, what FTIR can and cannot tell you, and how to build a workflow that turns your spectrometer into the trusted identification workhorse it was designed to be.

 

Why does my FTIR keep giving me low match scores?

Walk into most pharmaceutical QC labs and you will see some version of the same frustration. A technician places a powder loosely on the diamond crystal, presses the plunger halfway down, gets a poor match score and logs it as a suspected material failure. After years of working alongside QC teams across hundreds of laboratories, the Chemetrix team can tell you that this scenario almost always comes down to one of three things.

Poor ATR crystal contact: Infrared light only penetrates a few micrometres into the sample surface. Air gaps or inconsistent pressure mean the evanescent wave never reaches the material properly, producing a weak and noisy spectrum that will not match any reference cleanly.

Generic reference libraries: Most labs rely on commercial libraries built from a single reference sample under ideal conditions. When your actual material arrives with slight batch variation, a different particle size or minor additives, it will not match that idealised reference, even if it is exactly the right material.

Misplaced expectations: A match score measures similarity under the conditions of measurement. It is not an absolute verdict on material identity. Even a correct material from the correct supplier can return a score well below 100% if technique or library quality is off.

The good news is that all three of these problems are fixable.

What is FTIR actually measuring?

FTIR spectroscopy works by focussing on infrared light at a sample and measuring which wavelengths the material absorbs. Every compound has a unique pattern of absorption peaks, its molecular fingerprint. The ATR (attenuated total reflectance) method makes this fast and practical by bouncing the infrared beam off a diamond crystal in contact with the sample, requiring no preparation beyond placing the material on the sensor.

Library matching then compares your sample’s fingerprint to a reference spectrum using a mathematical correlation algorithm. The result is a match score, not a binary yes or no,
but a measure of how similar the two spectra are under the conditions of that measurement. Importantly, standard library search methods are designed to detect differences in the 5 to 10% range between a sample and its reference, which means some variation is expected
and entirely normal.

This is a critical distinction. Natural spectral variation occurs between batches of the same material due to:

  • Moisture content and surface effects
  • Particle size differences between suppliers or manufacturing runs
  • Trace additives or stabilisers that are entirely acceptable within specification

None of these make the material wrong. But all of them will affect your match score if your reference library was not built to account for them.

Here is the insight that changes everything:

FTIR is an identification tool, not a purity tool. It will tell you what something is. It will not tell you how pure it is or quantify trace impurities. That is the job of HPLC. Stop asking your FTIR to do HPLC’s work and start letting it be the world-class ID workhorse it was built to be.

How do you improve ATR sample preparation?

Consistent results require consistent technique.
These are the four rules that make the biggest difference:

Powders: Spread the sample evenly across the full crystal surface before pressing. Apply firm and consistent downward pressure using the sample press. If the signal is weak, press harder and recollect the background.

Hard solids: Press a flat face directly onto the crystal or grind a small portion to a fine powder first. A smooth surface fragment beats a large irregular chunk every time.

Pastes and semi-solids: Apply a thin even layer onto the ATR surface with a spatula. These conform naturally to the crystal and are the easiest sample type to handle well.

Crystal hygiene: Clean the crystal between every sample with an appropriate solvent and a lint-free cloth. A contaminated crystal from the previous sample is an invisible source of error that will affect match scores across multiple runs.

Standardising these steps into a written SOP, what Chemetrix calls the “SOP of the Squeeze”, is the single fastest way to improve reproducibility across your team.

How can you build a pharmaceutical FTIR library that actually works?

The solution to false rejections in pharmaceutical raw material identification is not to lower your acceptance thresholds. It is to build a smarter library. A site-specific library collects reference spectra from your own approved batches of each material, across multiple suppliers and multiple delivery lots, so that the natural variation of your actual materials is built into the reference from the start. When a new batch arrives with slightly different moisture content or particle size, your library recognises it as the correct material because it has seen that variation before.

The instrument that makes this possible: the Agilent Cary 630 FTIR

The Cary 630 is purpose-built for pharmaceutical QC applications. Its instrument configuration delivers energy throughput up to 30% greater than comparable routine FTIR systems, which means faster data collection, lower noise and more reliable spectra even when sample variation is present. Its diamond ATR crystal is impervious to abrasion, requires very small amounts of sample and is easy to clean between samples. Modular sampling accessories click in and out in seconds with no alignment required, and at just 20 x 20 cm on the bench and 3.8 kg, it lives where the work happens rather than in a centralised lab.

 

 

Most importantly, the Cary 630 runs Agilent MicroLab software, a method-driven and pictorial interface that makes building site-specific libraries an intuitive task rather than a data science project. MicroLab supports advanced classification methods including PLS-DA (partial least squares discriminant analysis). In published testing using the Cary 630 with MicroLab, a PLS-DA method achieved 100% correct classification of pharmaceutical samples and detected contaminants at levels as low as 0.5%. Results are displayed as colour-coded pass/fail indicators and automatically logged in 21 CFR Part 11 compliant audit trails.

This is what Chemetrix calls the Golden Reference Library: a site-specific and validated collection of spectra that reflects your materials, your suppliers and your real-world conditions. Not a generic database. Yours.

 

Practical resources:

What does a validated FTIR library mean for regulatory compliance?

For pharmaceutical manufacturers operating in a regulated environment, a site-specific library is not just a practical improvement. It is a compliance asset. The Cary 630 meets or exceeds the performance specifications of the US, European, Japanese, Chinese, Indian and International Pharmacopoeia. Its automated IQ/OQ qualification software generates documented and auditable performance reports covering wavenumber accuracy, spectral resolution and signal-to-noise ratio. MicroLab OQ handles qualification for the US, European and Indian Pharmacopoeia directly, while MicroLab PC can be configured for additional requirements including the Japanese Pharmacopoeia. The optional MicroLab Pharma software package adds full 21 CFR Part 11 and EU Annex 11 support including electronic signatures and data integrity controls.

 

But instrument qualification is only one part of the compliance picture. A validated reference library, with documented collection conditions, approved batch traceability and defined acceptance criteria, is what gives your QA team the scientific and regulatory confidence to act on FTIR results without
second-guessing every match score.

Chemetrix supports clients through the full validation process, from initial library design through to IQ/OQ documentation and method verification against pharmacopoeial requirements.


Practical resources:

📌 Contact Chemetrix to discuss validation support for your FTIR workflow.

There is a better way to run your QC lab

Too many pharmaceutical QC labs have quietly accepted that FTIR is unreliable. They have added extra retesting steps. They have lowered thresholds without understanding why. They have learned to work around the instrument rather than with it. That is not good science. And it is not a sustainable way to run a quality control operation. Chemetrix believes that every lab, regardless of its size, its budget or its current frustrations, deserves instrumentation that works, workflows that are documented and a team that understands what their results actually mean.

The Cary 630 is not just sold and installed. Chemetrix partners with your team through three practical engagement points:

  • Workflow audit: Identifying exactly why your current match scores are low and where the process is breaking down
  • Method development Assistance: Building and documenting the SOP of the Squeeze that standardises ATR technique across your team
  • Validation support: Ensuring your custom library meets the compliance requirements of your QC environment

When your library is right and your technique is standardised, FTIR stops being a source of anxiety. It becomes what it was always supposed to be: fast, reliable and auditable identification, every time.

 

Low FTIR match scores are almost never an instrument problem.
They are a library problem or a technique problem, and both are fixable.

The three things to take away from this article:

    • A match score measures similarity under the conditions of measurement. Natural batch variation, particle size differences and trace additives will affect it even when the
      material is correct.
    • ATR sample preparation technique has a bigger impact on match scores than most labs realise. Standardising your approach with a documented SOP is the fastest win available.
    • A site-specific library built from your own approved batches will outperform any generic commercial database for your materials, in your lab and from your suppliers.

The Agilent Cary 630 FTIR makes the instrument side of this straightforward. Chemetrix makes the rest straightforward too.

Ready to stop second-guessing your FTIR results?

📩 Contact the Chemetrix team to book a workflow audit, arrange a Cary 630 demonstration or discuss building your Golden Reference Library: chemetrix.co.za

Beyond the Bench: Why Partnership is the Critical Component in Pharmaceutical Analysis

In the pharmaceutical industry, the most valuable asset isn’t the active ingredient or the patented molecule – it is the integrity of the data that proves it works. In a sector governed by uncompromising regulatory standards, a laboratory’s reputation is built on its ability to produce consistent, compliant, and accurate results. However, as drug formulations grow more complex and detection limits move lower, many laboratories find that having the right equipment is only half the battle. The real challenge lies in the support system that keeps that equipment performing within the narrowest of margins.

At Chemetrix, we have been an authorised Agilent distributor in Southern and East Africa for decades. While our heritage is diverse, our commitment to the pharmaceutical sector is foundational. We don’t just supply instruments; we provide the technical scaffolding that allows pharmaceutical analysts to move from a raw sample to a validated report with total confidence.

Why great hardware isn’t enough

One of the most persistent challenges in the pharmaceutical workflow is the transition from a concept to a robust, validated method. It is a common misconception that high-end instrumentation automatically guarantees ease of use. In reality, pharmaceutical analysts often struggle with the “blank space” between unboxing an instrument and running their first compliant sample.

Whether you are identifying trace impurities, performing stability testing, or conducting complex bioanalysis, the method development phase is often where projects stall. A method that works in a controlled environment can fail in a high-throughput production setting if it hasn’t been stress-tested for robustness. This leads to a reactive cycle of troubleshooting and re-validation, which drains resources and delays time-to-market.

Navigating a shifting regulatory landscape

Data integrity is the non-negotiable cornerstone of the pharmaceutical industry. Global research shows that 90% of pharmaceutical professionals agree that reliable instruments are the single most important factor for a successful workflow. This is because, in this sector, a failure in reliability is a failure in compliance.

The pressure to process more samples while maintaining absolute adherence to 21 CFR Part 11 and EudraLex Annex 11 is immense. Without a partner who understands the nuances of IQ/OQ (Installation and Operational Qualification) and ongoing maintenance, labs risk falling into the “efficiency gap.” This is where sophisticated instruments sit underutilised because the method is too temperamental or the staff lack the specific training required to navigate the software’s compliance features.

Mastery of complex matrices with Agilent LC/MS

For laboratories tackling the most demanding pharmaceutical applications – such as nitrosamine analysis or impurity profiling– Agilent’s LC/MS solutions are globally recognised as the definitive standard. These systems provide the sensitivity and specificity required to detect analytes at levels that were previously unimaginable.

However, the “Chemetrix Edge” lies in how we support this technology. We recognise that method development for LC/MS is a specialised skill. Our support department acts as an extension of your own team, providing on-site assistance to help you develop, optimise, and troubleshoot your pharmaceutical methods. By leveraging our local application expertise, you can reduce the time spent in method development and ensure that your LC/MS system is performing at its peak from day one.

Driving throughput with the Agilent 1290 Infinity III LC

The workhorse of any modern pharmaceutical lab is the Liquid Chromatograph, and the Agilent 1290 Infinity III LC is engineered specifically for high-throughput environments. It is designed to handle the everyday pressures of pharmaceutical analysis with ultra-low carryover and exceptional pressure stability.

Chemetrix supports this hardware through a comprehensive service programme that goes beyond simple repairs. We offer tailored preventive maintenance and rapid-response technical support to ensure your 1290 Infinity III stays in a qualified state. By integrating our service expertise with this robust hardware, we help labs eliminate the “time traps” of manual intervention. Our goal is to ensure your staff spend less time worrying about baseline
drift and more time focusing on high-value data interpretation.

Agilent 1290 Infinity III LC

The reward of proactive support

The transition from a reactive laboratory to a proactive one is transformative. When you partner with a specialist who understands pharmaceutical applications, the results are measured in more than just uptime. You gain the peace of mind that comes from knowing your methods are robust, your instruments are qualified, and your data is defensible.

Our most successful pharmaceutical partners are those who have moved away from viewing instrumentation as a commodity and have embraced it as a collaborative workflow. This partnership leads to faster validation cycles, fewer “Out of Specification” (OOS) investigations, and a laboratory team that is empowered by their technology rather than frustrated by it.

 


Take the next step in laboratory excellence

The road to an optimised pharmaceutical workflow doesn’t have to be a solitary one. Whether you are looking to expand your LC/MS capabilities or need to refine the efficiency of your current chromatography setup, the expertise you need is available locally.

Your Action Plan:

Identify your most temperamental method – the one that requires the most manual intervention or frequent re-runs. Contact a Chemetrix specialist today for a workflow audit. Let’s work together to resolve your method development challenges and ensure your lab is equipped for the future of pharmaceutical discovery.

Accelerating Drug Development, QC & Manufacturing

During this webinar we will describe the newest breakthrough technologies and applications of Raman, Laser based Infrared and UV-Vis Spectroscopy in Pharma.

This will include use of transmission Raman as an alternative to UPHPLC for content uniformity and polymorph studies. Furthermore, use of a next generation IR instrument using a quantum cascade laser will be described for chemical imaging studies including analysis of tablet component distribution, polymorph distribution, salt exchange and stability studies. New breakthrough technologies for ultra-fast and productive parallel temperature based kinetic studies, protein folding, DNA melting and other temperature related UV-Vis measurements will end this overview.

 

Jan Wülfken
Product Specialist – Molecular Spectroscopy
Agilent Technologies

Dr. Wuelfken has worked for many years as Product Specialist for Agilent Technolgies in many region of the world, supporting Molecular ( Raman FTIR, Fluorescence nad UV-Vis/NIR) Spectroscopy business.

 

Register and watch on demand >

 

ICH Q3D Guideline: Elemental Impurities Analysis in Pharmaceutical Products

In the first half of this webinar, we will introduce the ICH/USP regulation and how to measure elemental impurities with the Agilent ICP-OES and/or ICP-MS instruments.

The second part of the webinar will focus on the Agilent software compliance solutions where you will see our options for data integrity as well as software features that simplify validating methods according to ICH/USP.

 

Uwe Noetzel
EMEAI Technical Coverage and Solutions
Agilent Technologies

Uwe joined Agilent as a GC/LC MS specialist in 1989. Since 1994 he is involved in ICP-MS as a Product Specialist. In 2001 he became part of the Agilent International Distributor Organization (IDO). Today his responsibility is the full Agilent Atomic Spectroscopy Portfolio in IDO

 

Andrew Brotherhood
Atomic Spectroscopy Application Engineer
Agilent Technologies

Andrew has over 15 years’ hands-on experience with ICP-MS, ICP-OES and Ion Chromatography instrumentation. He has mainly worked in the pharmaceutical analysis industry gaining significant experience with developing and validating methods to pharma regulations. Andrew started working for Agilent as a full time employee in January 2018 working as an Atomic Spectroscopy Application Engineer based at the Agilent Centre of Excellence in the UK.

 

Register and watch on demand >

 

Residual Solvent Analysis of Pharmaceutical Products

Organic solvents constitute a major fraction in the synthesis of pharmaceutical products. The manufacturing process for active pharmaceutical ingredients (APIs) may contribute to residual solvents remaining in the final product. Producers need to monitor and control the levels of residual solvents for several reasons—including safety, effect on crystalline form, solubility, bio-availability, and stability.

Therefore, all products must be tested to assess whether the solvents used during the manufacturing processes are within the accepted limits. Quality assurance laboratories routinely use the United States Pharmacopeia (USP) Method <467>.

 

Procedures for identification and quantification

The USP <467> monograph specifies the different classes of solvents per their toxicity, sets the concentration limits according to their health hazard, and describes the assay procedure for the solvents. A complete list of all the solvents that may be used in manufacturing processes is not mentioned under these classes. Therefore, the final products should be screened according to the solvents used during their specific manufacturing process.

The method is composed of three analytical procedures for identification and quantification.

  • Procedure A: Identification and limit testing. Uses a G43 phase (624-type column).
  • Procedure B: Confirms whether or not an identified solvent is above the regulated limits. Uses a G16 phase (WAX-type column).
  • Procedure C: Quantitative test using a G43 phase or G16 phase, depending on which produced fewer coelutions.

 

USP <467> analytical flowchart for residual solvent analysis.

 

Columns for excellent performance

Agilent J&W DB-Select 624 UI columns have shown excellent performance for residual solvent analysis according to USP <467> Procedure A. Repeatability was generally better than 2.5% RSD for Class 1, Class 2A, and Class 2B solvents. Once a residual solvent was identified above the permitted daily exposure (PDE) limit, Procedure B is performed to confirm analyte identity. The Agilent J&W DB-WAX UI GC column has been successfully used as a confirmation column, because it yields an alternate selectivity compared to that of a G43 column.

Agilent J&W DB-Select 624 UI columns

 

Recommended instruments

For this method, Chemetrix can recommend state-of-the-art analytical instruments. With best-in-class technology and powerful software, the Agilent 7697A headspace sampler is packed with the latest productivity-boosting features.  It’s unique sampling design allows you to use hydrogen as a carrier gas, delivering optimal chromatography and helping to future-proof your lab.

Agilent 7697A Headspace Sampler

 

Based on the Agilent Intuvo 9000 GC system, Agilent Residual Solvent Analyzers are factory pretested and preconfigured to deliver results, fast, while saving precious startup time. What’s more, their analytical precision exceeds USP method requirements for the three classes of residual solvents. It’s chemically tested to ensure optimal analysis of class 1 and class 2A/B solvents and labs can begin system calibration and validation immediately following installation.

Agilent Intuvo 9000 GC

 

A critical process

Residual Solvent Analysis is a must in any manufacturing environment where solvents form part of the production process. Because this process is so critical, using the correct instruments suited for the lab requirements can save time and boost accuracy.

 

Quality control at the heart of it all

At every stage of the quality control process, Chemetrix can assist labs with full end-to-end solutions for your residual solvent analysis. Our team of qualified professionals can share a comprehensive portfolio of solutions, including different instrument models, software and consumables, that work together to provide accurate and reproducible results.

 

Looking for more information on Residual Solvent Analyis? Watch our webinar >

 

Analysis of Nitrosamine Impurities in Pharmaceuticals

What you will learn

  • Understand what mutagenic impurities are and why it’s important to characterize and quantify them, even when present in trace amounts.
  • Understand the current regulatory guidelines for nitrosamines analysis in drug substance and product in Angiotensin II Receptor Blockers (sartan), ranitidine and metformin drugs
  • Learn about approaches for the prevention of the formation of GTIs and the confident identification and quantification of nitrosamines in APIs and drugs

 

Who should attend

  • Laboratory managers
  • Chromatographers
  • Analytical chemists and scientists
  • New product developers
  • Pharma manufacturing and quality control managers

 

Raman V.V.S.S. Nanduri, Ph.D.
Director,
Analys Lab Pvt. Lt

 

Register and watch on demand >

 

Geochemical Analysis at the Speed of Light with ICP-OES

Agilent Technologies understands the wide range of requirements in the geochemistry, mining and metals field. In order for you to be successful, we design our analysis instruments to operate in rugged environments at high productivity levels with minimal user training needed. Whether you are determining major or trace analytes in steel or alloy samples, determining gold, silver and platinum group elements in ore grade material, analyzing plating solutions or performing geochemical mapping, Agilent provides you with the ease-of-use and reliability required in handling the most refined and the most difficult samples. We enhance the flexibility of our instruments by offering systems that deliver higher productivity without sacrificing performance; and flexibility so you can quickly and easily handle complex matrices. Depending on sample concentrations and the number of analyses performed, Agilent offers a best-in-class system specifically designed for your needs.

In this webinar, we will look how Agilent’s ICP-OES offering can speed up your Geochemical Analysis.

 

Register Here >

 

Rapid QC Tablet Testing with Transmission Raman Spectroscopy

The Agilent TRS100 Raman system is ideal for fast assay of tablets, capsules, and other dosage forms. Transmission Raman technology from Agilent enables simple method-development and deployment in QC applications. It is easy to implement in analytical laboratories and production areas, and has regulatory approvals for content uniformity (CU), assay, and identification (ID) applications. This online seminar provides a comprehensive introduction to the Transmission Raman technology and the Agilent TRS100 Raman system in the pharmaceutical quality-control applications.

 

Speakers

Yanqia Wang, PhD, Application Engineer, Molecular Spectroscopy, Agilent Technologies, Inc.

Dr. Yanqia Wang started working for Agilent Technologies Inc. as a FTIR application Engineer in 2013, providing pre-&post-sale application support. The products he covers from Bench-top FTIR microscopes to various Mobile FTIR spectrometers. Dr. Wang received his PhD of analytical chemistry from Duke University in 2004, doing dynamic IR spectroscopy research. Then he joined Fitzpatrick Center for Photonics at Duke University, doing Tissue Raman spectrometer instrumentation. Since 2007, Dr. Wang worked for Avery Dennison Corp. as a spectroscopist, providing molecular analytical support to the research & development.

 

Register Here >

 

Cleaning Validation – A Beginner’s Guide to Increasing Efficiency with TOC

Join our webinar which will guide you through efficiency gains with TOC for cleaning validation. We call it a ‘beginner’s guide’, but this webinar will benefit long-time TOC users as well as those new to using TOC for cleaning validation. We will cover step-by-step the ‘what, why, and how’ for gaining efficiency and getting the most out of TOC for cleaning validation.

Register Here >

 

A New Endotoxin Testing Platform: Sievers Eclipse BET

In this webinar, attendees will receive an introduction to the groundbreaking Sievers Eclipse BET Platform to understand why it was created and how it works to simplify and automate endotoxin assay setup, while maintaining full compliance with USP <85>. With Eclipse, compliant 21-sample assays can be set up in as little as 9 minutes, leading to substantial efficiency gains.

This webinar will also focus on how to evaluate this revolutionary technology. From comparability of analytical results across platforms to data integrity and validation testing, this webinar will leave attendees with a solid understanding of how the Eclipse platform stacks up next to other technology on the market, and how it can be evaluated and validated in a QC lab to demonstrate viability for routine endotoxin testing.

 

In this webinar you’ll learn:

  • Why and how the Sievers Eclipse platform was developed
  • How the Eclipse platform increases efficiency and automates endotoxin testing
  • How the Eclipse platform aligns with USP <85>, EP 2.6.14, and JP 4.01
  • Comparability of analytical results across different platforms
  • Data integrity
  • Validation testing and validation tools available to customers

 

Who should attend:

  • QA & QC personnel
  • Microbiology personnel
  • Validation personnel
  • Metrology personnel
  • Operations personnel

 

 Register Here >